Apeloa Pharmaceutical Co.,Ltd
000739
Rankning i aktier
#4287
Apeloa Pharmaceutical Co.,Ltd operates as a comprehensive pharmaceutical... Apeloa Pharmaceutical Co.,Ltd operates as a comprehensive pharmaceutical enterprise, specializing in the discovery, development, production, and global distribution of a diverse range of medicinal products. Its market reach spans China and various international territories. The company strategically focuses its product portfolio on several critical medical fields, including cardiovascular and cerebrovascular health, anti-infective treatments, antiviral therapies, and oncology (cancer treatment), alongside other therapeutic categories. Apeloa's offerings encompass finished pharmaceutical preparations, raw material intermediates (active pharmaceutical ingredients and their precursors), and veterinary medicines. These products are primarily recognized and sold under key brands such as Tianliwei, Beshin, Yosemade, and Jutai, among others. Furthermore, the company extends its expertise to other pharmaceutical businesses by providing contract research, development, and manufacturing (CDMO) services. The corporate headquarters for Apeloa Pharmaceutical Co.,Ltd are located in Dongyang, China.
Aktiekurs
$3.13
Marknadsvärde
$3.62B
Förändring (1 dag)
-1.42%
Förändring (1 år)
46.59%
Land
CN
Handel Apeloa Pharmaceutical Co.,Ltd (000739)
Kategori
Healthcare
P/B-tal för Apeloa Pharmaceutical Co.,Ltd (000739)
P/B-tal per October 2026 TTM: 3.59
Enligt Apeloa Pharmaceutical Co.,Ltd senaste finansiella rapporter och aktiekurs är det aktuella P/B-talet (TTM) 3.59. I slutet av 2024 hade företaget ett P/B-tal på 2.79.
Historik för P/B-tal för Apeloa Pharmaceutical Co.,Ltd från 2000 till 2026
P/B-tal vid årets slut
| År | P/B-tal | Ändra |
|---|---|---|
| 2026 (TTM) | 3.59 | 21.27% |
| 2025 | 2.96 | 5.96% |
| 2024 | 2.79 | -4.02% |
| 2023 | 2.91 | -36.30% |
| 2022 | 4.57 | -44.09% |
| 2021 | 8.17 | 30.79% |
| 2020 | 6.25 | 54.03% |
| 2019 | 4.06 | 55.35% |
| 2018 | 2.61 | 6.58% |
| 2017 | 2.45 | -25.52% |
| 2016 | 3.29 | -15.47% |
| 2015 | 3.89 | 8.52% |
| 2014 | 3.59 | 61.94% |
| 2013 | 2.21 | 84.56% |
| 2012 | 1.20 | -71.82% |
| 2011 | 4.26 | 43.16% |
| 2010 | 2.97 | -10.68% |
| 2009 | 3.33 | 131.56% |
| 2008 | 1.44 | -62.40% |
| 2007 | 3.82 | 20.96% |
| 2006 | 3.16 | 103.63% |
| 2005 | 1.55 | -23.64% |
| 2004 | 2.03 | -11.01% |
| 2003 | 2.29 | -41.50% |
| 2002 | 3.91 | -43.69% |
| 2001 | 6.94 | 17.81% |
| 2000 | 5.89 | 0.00% |
P/B-tal för liknande företag eller konkurrenter
| Företag | P/B-tal | Skillnad i P/B-tal | Land |
|---|---|---|---|
| 1.9834 | -44.75% |
DE
|
|
| 2.1139 | -41.11% |
DE
|
|
| 1.3124 | -63.44% |
JP
|
|
| 6.3468 | 76.81% |
CH
|
|
| 5.041 | 40.43% |
IN
|
